US 12065458
Trialkyne linking agents and methods of use
granted A61KA61K47/545
Quick answer
US patent 12065458 (Trialkyne linking agents and methods of use) held by Arrowhead Pharmaceuticals, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/545